- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05072769
Date Consumption and Uterine Involution
The Effect of Date Consumption in the Early Postpartum Period on Uterine Involution
There are many studies in the literature examining the effects of dates on pregnancy, birth and postpartum processes. However, no study has been found that examines the effect of women on the involution process in the early postpartum period. It is thought that this study will fill the gap in the literature with this study, which was conducted to determine the effect of date fed to women in the early postpartum period on uterine involution.
The study was planned as a randomized controlled and experimental study to determine the effect of date fed to women in the early postpartum period on uterine involution.
It will be held in the postpartum service of Sakarya University Training and Research Hospital between October - April 2021.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
There are many studies in the literature examining the effects of dates on pregnancy, birth and postpartum processes. However, no study has been found that examines the effect of women on the involution process in the early postpartum period. It is thought that this study will fill the gap in the literature with this study, which was conducted to determine the effect of date fed to women in the early postpartum period on uterine involution.
The study was planned as a randomized controlled and experimental study to determine the effect of date fed to women in the early postpartum period on uterine involution.
It will be held in Sakarya University Training and Research Hospital delivery room and postpartum service between October - December 2021.
The universe of the study will be women who gave vaginal birth between October and December 2021 in the delivery room and puerperal service department of Sakarya University Training and Research Hospital, and the sample will be 60 women (30 experimental group-30 control group).
Which of the women forming the sample group will be included in the experimental/intervention and control groups will be determined by simple randomization. A "random number generation program (research randomizer)" will be used in the randomization of the sample, and randomization with this program will be done by an unbiased researcher who is not involved in the research.
The implementation phase of the research will start after the third stage of labor (after the fetus and its appendages are born) ends. After the mother is stabilized, the "Descriptive Demographic Information Form" will be filled in for the experimental and control groups, and then blood samples will be taken from the mothers in order to determine the hemoglobin, hematocrit and oxytocin values. Since the blood sample will be taken from the intravenous line opened for emergencies during labor, an additional invasive procedure will not be applied to the patients. After the first blood sample is taken, 100gr (5-6 pieces) of Deglet Noor dates will be given to the experimental group and asked to be consumed within one hour. At this stage, the practices will continue in accordance with the hospital routines for the mothers in the control group. At the 6th hour after the third stage of labor, blood samples will be taken again to determine the hemoglobin, hematocrit and oxytocin values, and the application will end. In the postpartum ward, where the study will be conducted, routine blood samples are taken at the 6th hour after birth, so invasive intervention will be avoided.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Yasemin Hamlacı Başkaya, Dr
- Phone Number: +90 295 295 43 31
- Email: yhamlaci@sakarya.edu.tr
Study Locations
-
-
-
Sakarya, Turkey, 54050
- Sakarya University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Volunteer to participate in the research,
- Primiparous,
- Not induction during birth,
- Born at term and healthy (38-42 weeks old, born 2500-4000gr, born with 5th minute apgar 7 and above, no known congenital disease),
- Not given oxytocin in the postpartum period,
- No oral intake restriction after controlling for postpartum uterine involution,
- Over 18 years of age who gave vaginal birth,
- It is planned to include mothers who can speak Turkish.
Exclusion Criteria:
- Not willing to participate in the research,
- Risk of postpartum bleeding in the first hour after delivery,
- Having a health problem in which the mother or baby is at risk,
- Not breastfeeding her baby
- Having a disease that prevents breastfeeding,
- Those whose hemoglobin value is below 10 g/dl,
- Cesarean delivery,
- Have a blood disease,
- The baby was taken to the neonatal intensive care unit,
- It is planned not to include mothers with diabetes.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Experimental group
After the fetus and placenta are born, feeding 100 gr (5-6 pieces) dates to the experimental group
|
Within the first hour after birth, 100gr (5-6 pieces) dates will be eaten.
|
|
NO_INTERVENTION: Control group
The group that was not attempted any intervention in the postpartum period
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hemoglobin values
Time Frame: 6 hours
|
Approximately 500 ml of blood is lost in vaginal delivery.
Blood loss exceeding 500 ml in the postpartum period is a sign of bleeding.
therefore, the involution process will be defined with the changes in hemoglobin (gr/dl) immediately after birth and 6 hours after birth.
|
6 hours
|
|
Hematocrit values
Time Frame: 6 hours
|
More than 10% decrease in the postpartum period compared to the prenatal period indicates bleeding.
Therefore, the hematocrit (gr/dl) changes immediately after birth and 6 hours after birth will define the involution process.
|
6 hours
|
|
Oxytocin values
Time Frame: 6 hours
|
Oxytocin, which is produced in the hypothalamus and enters the circulation from the posterior pituitary, is a hormone that prevents postpartum hemorrhage by regulating the intensity and rhythm of postpartum uterine contractions.
For this reason, the involution process will be defined by looking at oxytocin releases immediately after birth and 6 hours after birth.
|
6 hours
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Kevser Özdemir, Dr, Sakarya University
Publications and helpful links
General Publications
- Razali N, Mohd Nahwari SH, Sulaiman S, Hassan J. Date fruit consumption at term: Effect on length of gestation, labour and delivery. J Obstet Gynaecol. 2017 Jul;37(5):595-600. doi: 10.1080/01443615.2017.1283304. Epub 2017 Mar 13.
- Al-Kuran O, Al-Mehaisen L, Bawadi H, Beitawi S, Amarin Z. The effect of late pregnancy consumption of date fruit on labour and delivery. J Obstet Gynaecol. 2011;31(1):29-31. doi: 10.3109/01443615.2010.522267.
- Kordi M, Meybodi FA, Tara F, Fakari FR, Nemati M, Shakeri M. Effect of Dates in Late Pregnancy on the Duration of Labor in Nulliparous Women. Iran J Nurs Midwifery Res. 2017 Sep-Oct;22(5):383-387. doi: 10.4103/ijnmr.IJNMR_213_15.
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 48535046780
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Early Postpartum Hemorrhage
-
Assuta Ashdod HospitalCompletedAnemia | Episiotomy Wound | Hemoglobin | Early Postpartum HemorrhageIsrael
-
Dangana Zakari AdekaWest African College of Surgeons (WACS)CompletedPostpartum Hemorrhage (PPH) | Postpartum Hemorrhage Third Stage of Labour Retained PlacentaNigeria
-
University Hospital, Clermont-FerrandUnknownPostpartum Depression | Postpartum Hemorrhage | Postpartum Women | Postpartum Stress | Postpartum AnxietyFrance
-
ResQ Medical LtdRecruitingPPH | Postpartum Hemorrhage \(PPH\) | Postpartum Hemorrhage \(Primary\)Kenya
-
Cairo UniversityUnknownHemorrhage, PostpartumEgypt
-
Columbia UniversityCompletedHemorrhage, PostpartumUnited States
-
Ain Shams Maternity HospitalUnknownHemorrhage PostpartumEgypt
-
Chelsea and Westminster NHS Foundation TrustCompleted
-
Samuel Lunenfeld Research Institute, Mount Sinai...RecruitingPostpartum Hemorrhage (Primary)Canada
-
Megan LordThermaSENSE CorpCompletedHemorrhage | Vasoconstriction | Hemorrhage, PostpartumUnited States
Clinical Trials on Date Fruit
-
Selcuk UniversityCompletedLabor | Augmentation | Induction | Stimulation, SelfTurkey
-
University of ReadingCompleted
-
King Saud UniversityCompletedGlycaemic Response MeasurementsSaudi Arabia
-
Newcastle UniversityCompletedMood and Cognitive PerformanceUnited Kingdom
-
University Hospital, MontpellierCompleted
-
Medical University of ViennaUnknownAdvanced Non-small-cell Lung CancerAustria
-
Ocean Spray Cranberries, Inc.Completed
-
State University of New York at BuffaloEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted
-
Northeastern UniversityRhode Island HospitalCompleted
-
Bahria UniversityActive, not recruiting